Theoretical consideration of drug distribution kinetics in a noneliminating organ: comparison between a "homogeneous (well-stirred)" model and "nonhomogeneous (tube)" model
- PMID: 4087165
- DOI: 10.1007/BF01065656
Theoretical consideration of drug distribution kinetics in a noneliminating organ: comparison between a "homogeneous (well-stirred)" model and "nonhomogeneous (tube)" model
Abstract
Drug distribution kinetics in a noneliminating organ or tissue has been mathematically examined. The homogeneous (well-stirred) model regards the noneliminating organ or tissue as a homogeneous compartment in which the drug is equilibrated with that in the blood leaving the organ or tissue. The nonhomogeneous (tube) model views the noneliminating organ or tissue as comprising a number of parallel cylindrical tubes containing binding sites distributed homogeneously along these tubes. These two models are examined, considering the pseudo-distribution equilibrium phase after bolus injection and a linear binding condition. Although both models predict a similar tissue distribution under a variety of conditions, significant differences exist in the predictions of various pharmacokinetic parameters as a function of the drug distribution, such as blood flow, organ volume, slope of the terminal phase, and the tissue-to-blood partition coefficients. The predictability and limitations of these two models are explored. Distribution characteristics of the two models are also examined for adriamycin, actinomycin D, tetrachlorobiphenyl, hexachlorobiphenyl, digoxin, and ethoxybenzamide; no difference is observed. It is concluded that the assumption of a homogeneous (well-stirred) compartment is suitable for describing the drug distribution kinetics of these drugs.
Similar articles
-
Pharmacokinetic concepts - drug binding, apparent volume of distribution and clearance.Eur J Clin Pharmacol. 1981;20(4):299-305. doi: 10.1007/BF00618781. Eur J Clin Pharmacol. 1981. PMID: 7308282
-
Hepatic elimination of drugs with concentration-dependent serum protein binding.J Pharmacokinet Biopharm. 1984 Feb;12(1):67-81. doi: 10.1007/BF01063611. J Pharmacokinet Biopharm. 1984. PMID: 6747819
-
A valid equation for the well-stirred perfusion limited physiologically based pharmacokinetic model that consistently accounts for the blood-tissue drug distribution in the organ and the corresponding valid equation for the steady state volume of distribution.J Pharm Sci. 2010 Jan;99(1):475-85. doi: 10.1002/jps.21798. J Pharm Sci. 2010. PMID: 19492340
-
A review of metabolite kinetics.J Pharmacokinet Biopharm. 1985 Dec;13(6):633-62. doi: 10.1007/BF01058905. J Pharmacokinet Biopharm. 1985. PMID: 3914545 Review.
-
First-pass elimination. Basic concepts and clinical consequences.Clin Pharmacokinet. 1984 Jan-Feb;9(1):1-25. doi: 10.2165/00003088-198409010-00001. Clin Pharmacokinet. 1984. PMID: 6362950 Review.
Cited by
-
The assessment of bioavailability in the presence of nonlinear elimination.J Pharmacokinet Biopharm. 1988 Jun;16(3):263-78. doi: 10.1007/BF01062137. J Pharmacokinet Biopharm. 1988. PMID: 3221326
-
The uptake and elution of lignocaine and procainamide in the hindquarters of the sheep described using mass balance principles.J Pharmacokinet Biopharm. 1988 Feb;16(1):31-40. doi: 10.1007/BF01061861. J Pharmacokinet Biopharm. 1988. PMID: 3373418
-
A whole-body physiologically based pharmacokinetic model incorporating dispersion concepts: short and long time characteristics.J Pharmacokinet Pharmacodyn. 2001 Feb;28(1):27-55. doi: 10.1023/a:1011565602152. J Pharmacokinet Pharmacodyn. 2001. PMID: 11253612
-
A physiologically based pharmacokinetic model incorporating dispersion principles to describe solute distribution in the perfused rat hindlimb preparation.J Pharmacokinet Biopharm. 1997 Aug;25(4):389-412. doi: 10.1023/a:1025788824946. J Pharmacokinet Biopharm. 1997. PMID: 9561486
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical